002462 Cachet Pharmaceutical
WatchlistCachet Pharmaceutical News
Jiashitang: 2021 Stock Equity Distribution Implementation Notice
Gashido: Announcement of 2021 Profit Distribution Plan
Jiashitang: Announcement on the proposed public listing and transfer of 51% of Shaanxi Jiashitang Pharmaceutical Co., Ltd.
Gashitang: Announcement on the results of the issuance of accounts receivable asset-backed notes
Jiashitang: Notice on Issuance of Accounts Receivable Asset-Backed Notes and Obtaining Registration by the China Interbank Market Dealers Association
Jiashitang: Summary of Report on Issuance of Shares to Purchase Assets and Related Transactions (Draft) (Revised Draft)
Gashitang: Announcement on progress in the sale of financial assets available for sale
Jiashitang: Announcement on the acquisition and capital increase of part of two companies, including Jiangsu Yikeda Medical Technology Co., Ltd., owned and actually controlled by Jia Wei and Zhou Min
Jiashitang: Announcement on the acquisition of some shares and capital increases in five companies including Su Haijun and Beijing Erreguen Trading Co., Ltd., which is owned and actually controlled by Zhang Jie
Jiashitang: Announcement on the acquisition and capital increase of part of five companies including Guangzhou Jijian Trading Co., Ltd. owned and actually controlled by Shen Xuedi, Zhou Qing, Wang Manhui, and Zhang Chuan
Gashitang: Announcement on Sale of Financial Assets Available for Sale and Resumption of Trading
Jiashitang: Announcement on the completion of the listing and transfer of 100% of the shares of Beijing Jiashi Daheng Pharmaceutical Co., Ltd. and 75% of the shares of Beijing Daheng Beisheng Pharmaceutical Co., Ltd.
Jiashitang: Notice on the subsequent progress of the listing and transfer of 100% of the shares of Beijing Jiashi Daheng Pharmaceutical Co., Ltd. and 75% of the shares of Beijing Daheng Beisheng Pharmaceutical Co., Ltd. (1)
Jiashitang: Announcement on the listing and transfer of 100% of the shares of Beijing Jiashi Daheng Pharmaceutical Co., Ltd. and 75% of the shares of Beijing Daheng Beisheng Pharmaceutical Co., Ltd.
Jiashitang: China Securities Regulatory Commission's approval for the company's initial public offering of shares